Oct 2026· Archives of Clinical Neuropsychology· Vol 41, pp. ii41-ii41· 0 citations
TL;DR
Associations between VRB and NFTs may vary as a function of PWB, suggesting associations between VRB and NFTs may vary as a function of PWB.
Abstract
Objective: Vascular risk burden (VRB) influences Alzheimer’s disease (AD) through biological, behavioral, and psychosocial pathways. Psychological well-being (PWB), a multidimensional construct of positive psychological functioning, is independently linked to VRB and resilience in brain aging. However, less is known about whether these factors operate jointly or whether PWB influences associations between VRB and neuropathology. This study examined whether PWB moderates the relationship between VRB and AD neuropathology, hypothesizing that higher PWB would attenuate these associations. Method/Data Selection: Participants were 1,270 autopsied older adults from the Rush Alzheimer’s Disease Consortium (RADC; mean age = 81.17; mean education = 15.19 years; 73.3% female; 19.4% apolipoprotein E ε4 [APOE ε4] carriers). PWB was assessed using Ryff’s 18-item scale. VRB was an ordinal composite of hypertension, diabetes, and smoking history. Outcomes included square-root-transformed β-amyloid (Aβ) and tau neurofibrillary tangles (NFTs). Generalized linear models tested associations and moderation, adjusting for age, sex, education, and APOE ε4 status. Results/Data Synthesis: PWB was not associated with VRB (OR = 0.86, 95% CI [0.68, 1.10]) or Aβ (β = 0.044). Greater VRB was associated with Aβ (β = -0.050, p = .049) and NFTs (β = -0.117, p < .001). The VRB × PWB interaction was not significant for Aβ (β = -0.075, p = .227) but was significant for NFTs (β = -0.184, p = .014), such that VRB was associated with NFTs at mean and high PWB but not at low PWB. Conclusions: PWB moderated the relationship between VRB and NFTs. These findings suggest associations between VRB and NFTs may vary as a function of PWB.
Abstract INTRODUCTION Apolipoprotein E (APOE) ‐ε4 and social determinants of health (SDoH) are major Alzheimer's disease (AD) risk factors, yet whether SDoH modify the relationship between APOE‐ε4, AD pathology, and cognition remains unclear. METHODS Using Biobank for Aging Studies (BAS) data, we assessed APOE‐ε4 using...
Naomi V. Ferreira, L. Bertola, R. Paradela et al.· Alzheimer's & Dementia· 0 citations
Up to 45% of dementia can be prevented by addressing modifiable risk factors. Brain Health Services (BHS) are emerging across Europe, targeting individuals with subjective cognitive decline (SCD) to assess, communicate and reduce their risk of dementia. Our aim is to characterize our BHS cohort, and assess differences...
F. E. Pozzi, Francesca Solivani, I. Vitagliano et al.· Neurological Sciences· 0 citations
Network-specific associations between cardiometabolic risk and DMN organization are suggested to be detectable in indi viduals with MCI, a clinical state preceding dementia, as well as in some degree within cognitively unimpaired individuals.
Zachary D. Green, S. O'Bryant, L. Johnson et al.· Frontiers in Neuroscience· 0 citations
Objective: Intra-individual cognitive variability (IICV) is an important marker of cognitive functioning in aging and neurological disease. Whether IICV may serve as a pathway to explain the effect of mild cognitive impairment (MCI) on cognition has not been reported. Therefore, we investigated whether IICV mediated...
Dana L. Hirst, R. Holtzer· Archives of Clinical Neurops...· 0 citations
Objective: This review examines the relationship between depression and the development of Alzheimer’s disease (AD) in older adults, evaluating its impact on cognitive decline and neuropsychological functioning. The goal is to clarify the role of late-life and chronic depressive symptoms in the progression of AD, wit...
Bhumi N. Patel, E. Cesar· Archives of Clinical Neurops...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.